In order to prevent spam,
this email address cannot be copied.
Researcher Profile - Mark E. Obrenovich Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Community: Researcher Profiles
Researcher Profile

RESEARCHER INFORMATION
First Name:Mark E.
Last Name:Obrenovich
Affiliation:Case Western Reserve University
Department:Pathology
Country/Territory:U.S.A.
Email Address: 
Disclosure:
(view policy) 
Member reports no financial or other potential conflicts of interest. [Last Modified: 24 May 2004]
View all comments by Mark E. Obrenovich
Clinical Interests:
Alzheimer Disease, Prion Diseases, Aging Process, Parkinson Disease, Neurodevelopmental Disorders (Down syndrome, etc.), Tauopathies
Research Focus:
A-beta PP/A-beta, Oxidative Stress, Proteomics, Protein structure/chemistry, Chemistry/Pharmacology, Microscopy, Signal transduction, Molecular and Cell biology, Apoptosis/Cell cycle
Work Sector(s):
University, University
Web Sites:
Professional: www.case.edu
Researcher Bio
Biographical Sketch



Mark E. M. Obrenovich, B.Sc., M.Sc.
Graduate Student
Department of Pathology
Case Western Reserve University
Institute of Pathology
2085 Adelbert Rd,
Cleveland Ohio 44106
Phone: (216) 368-6238 FAX: (216) 368-0495
E-mail address: meo5@po.cwru.edu

Research interests: Mechanisms of aging, mortality, and longevity, Diabetes, Alzheimer Disease and Lenticular Aging and Cataractogenesis

Current status: Citizen of the United States.


EDUCATION:

Ph.D Cellular and Molecular Basis of Disease, 2003-present,
Case Western Reserve University, Cleveland, OH

M.Sc.: Cellular and Molecular Basis of Disease, 2003,
Case Western Reserve University, Cleveland, OH

Thesis Title: NeurofibrillaryTangles and Senile Plaques –Giving a “Voice” to Alzheimer Disease, January 2003.

Research Advisor: Professor Mark A. Smith

B.Sc.: Biology cum laude, 1994-1998, Cleveland State University, Cleveland, OH Two Time President’s Medal recipient

B.A.: Fine Arts cum laude, 1994-1998, Cleveland State University, Cleveland, OH President’s Medal recipient

A.A.: Social Science cum laude, 1989-1991, Bowling Green State University, Bowling Green, OH
Top Papers
Mark E. Obrenovich and Vincent M. Monnier Glycation predisposes to amyloid formation Glycation offers new clues into the etiology of “conformational” diseases Science's SAGE KE Sci Aging Knowledge Environ. 2004 Jan 14;2004(2):pe3 http://sageke.sciencemag.org/cgi/.

Obrenovich ME., Smith M.A. Perry G. and Aliev G. Morphological features of the changes of arterial vessels endothelium after ischemia and following reperfusion. Journal of Submicr. Cytol. Pathol., 2004 (Revised).

Obrenovich ME., Smith M.A. Perry G. and Aliev G. Functional and Morphological characteristics of aortic endothelium by using different methods of their prevention after ischemia and hypoxia. Journal of Submicr. Cytol. Pathol., 2004 (Accepted for Publication).

Rutter K, Sell DR, Fraser N, Obrenovich M, Zito M, Starke-Reed P, Monnier VM. Green tea extract suppresses the age-related increase in collagen crosslinking and fluorescent products in C57BL/6 mice. Int J Vitam Nutr Res. 2003 Nov;73(6):453-60.

Mark E. Obrenovich and Vincent M. Monnier Vitamin B1 Blocks Damage Caused by Hyperglycemia Will thiamine offer a simple solution to complications of diabetes? Science's SAGE KE Sci Aging Knowledge Environ. 2003 Mar 12;2003(10):PE6, http://sageke.sciencemag.org/cgi/ .

Sell DR, Lane MA, Obrenovich ME, Mattison JA, Handy A, Ingram DK, Cutler RG, Roth GS, Monnier VM. The effect of caloric restriction on glycation and glycoxidation in skin collagen of nonhuman primates. J Gerontol A Biol Sci Med Sci. 2003 Jun;58(6):508-16.

Aliev G, Smith MA, Obrenovich ME, de la Torre JC, Perry G. Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease. Neurotox Res. 2003;5(7):491-504

Atwood CS, Obrenovich ME, Liu T, Chan H, Perry G, Smith MA, Martins RN. Amyloid-beta: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-beta Brain Res Brain Res Rev. 2003 Sep;43(1):1-16.

Obrenovich, M. E.; Raina, A. K.; Ogawa, O.; Atwood, C. S.; Smith, M. A. Alzheimer Disease – A New Beginning, Or A Final Exit?, Cell-Cycle Mechanisms in Neuronal Death Nicoletti, Ferdinando, Agata Copani Landis Biosciences (in press).

Monnier VM and Obrenovich ME. Wake up and smell the maillard reaction. Sci Aging Knowledge Environ. 2002 Dec 18;2002(50):pe21

Obrenovich, M. E.; Atwood, C. S.; Joseph, J. A.; Perry, G.; Smith, M. A. Amyloid-ß: A (Life) Preserver For The Brain, Neurobiology of Aging. Neurobiology of Aging. Dec 2002.
What is the greatest void to date in our knowledge of Alzheimer's Disease?
Alternative views and a comprehensive understanding of the role of amyloid beta and tauopathies in AD.
What are the top three papers (not yours) you have read recently?
B. Bouma, L. M. Kroon-Batenburg, Y. P. Wu, B. Brunjes, G. Posthuma, O. Kranenburg, P. G. De Groot, E. E. Voest, M. F. Gebbink, Glycation Induces Formation of Amyloid Cross-Beta Structure in Albumin. J Biol Chem. 278, 41810-41819 (2003).

If resources were not limited, what research projects would you pursue?
Inhibitors of glycation to prevent amyloidosis or deglycating enzymes to treat AD
What is your leading hypothesis?
Glycation and oxidative stress predispose to amyloidogenesis and impaired clearence by the ubiquitin-proteasome system in multi-disease systems.
What piece of missing evidence would help prove it?
deglycation of amyloid plaques and intracellular inclusions would facilitate clearence of the deposits
What is your fallback position?
glycation is regulated to some extent and loss of endogenous protective regulatory mechanisms leads to accumulation of inclusions or deposits

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad